<DOC>
	<DOCNO>NCT00449865</DOCNO>
	<brief_summary>The purpose trial determine nutritional supplement creatine slow progression Parkinson 's disease time .</brief_summary>
	<brief_title>NET-PD LS-1 Creatine Parkinson 's Disease</brief_title>
	<detailed_description>Parkinson 's disease ( PD ) affect nearly million Americans , number increase come decade population age . Symptoms PD may include tremor , rigidity stiffness limbs trunk , slowness movement , impaired balance coordination . These problem occur PD worsens , brain cell control body movement die . This study determine creatine——an investigational compound——is able slow progression PD . Creatine , widely use dietary supplement think improve exercise performance . In animal model human study , creatine show well tolerate may ability protect brain cell . In NET-PD LS-1 study , 1,720 participant randomly assign receive either creatine placebo ( inactive substance ) . Participation study last minimum 5 year include least 9 follow-up clinic visit least 3 telephone call .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Willing able give inform consent willing commit longterm followup PD ( asymmetric feature include slowness ( bradykinesia ) plus rest tremor and/or rigidity ) within 5 year diagnosis Treated/responsive dopaminergic therapy ( dopamine agonist levodopa ) least 90 day , 2 year . Use creatine 14 day prior baseline study History know hypersensitivity intolerability creatine Any unstable clinically significant condition would impair subject 's ability comply long term study followup Other know suspect cause parkinsonism ( e.g . metabolic , drug induce , etc . ) , significant feature suggestive diagnosis atypical parkinsonism .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>creatine</keyword>
	<keyword>NET-PD</keyword>
	<keyword>neuroprotection</keyword>
	<keyword>PD</keyword>
</DOC>